The significance of E266K polymorphism in the NOD1 gene on Helicobacter Pylori infection: An effective force on pathogenesis?

Clinical and Experimental Medicine

Volumn 10, Issue 2, 2010, Pages 107-112

  Kara, Banu ^a   Akkiz, Hikmet ^a   Doran, Figen ^a   Bayram, Suleyman ^a   Erken, Eren ^a   Gumurdullu, Yuksel ^a   Sandikci, Macit ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Atrophy; CagA; Helicobacter pylori; Intestinal metaplasia; NOD1 E266K polymorphism

Indexed keywords

BISMUTH CITRATE; CAGA PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 4; LANSOPRAZOLE; METRONIDAZOLE; TETRACYCLINE; NOD1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; ATROPHY; BACTERIAL GENE; BACTERIAL STRAIN; DISEASE SEVERITY; DNA POLYMORPHISM; EPITHELIUM CELL; FEMALE; GASTRITIS; GENE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; METAPLASIA; MUTANT; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH EPITHELIUM; TREATMENT FAILURE; WILD TYPE; ATROPHIC GASTRITIS; BACTERIAL COUNT; GENETIC POLYMORPHISM; GENETICS; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MISSENSE MUTATION; PATHOLOGY; STOMACH;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

ADULT; COLONY COUNT, MICROBIAL; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED; MUTATION, MISSENSE; NOD1 SIGNALING ADAPTOR PROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEVERITY OF ILLNESS INDEX; STOMACH;

EID: 77954681864     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-009-0077-6     Document Type: Article

References (55)

1. Polenghi A, Bossi F, Fischetti F, Durigutto P, Cabrelle A, Tamassia T, Cassatella MA, Montecucco C, Tedesco F, Bernard M (2007) The neutrophil activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vitro. J Immunol 178:1312-1320
2. Backert S, Ziska E, Brinkman V, Zimmy-Arndt U, Fauconnier A, Jungblut PR, Naumann M, Meyer FT (2000) Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type 4 secretion apparatus. Cell Microbiol 2:155-164
3. Amieva MR, El-Omar EM (2008) Host bacterial interactions in Helicobacter pylori infection. Gastroenterology 134:306-323
4. George JT, Boughan PK, Karageorgiou H, Bajaj-Eliot M (2003) Host anti-microbial response to Helicobacter pylori infection. Mol Immunol 40:451-456
5. D'Ellos MM, Andersen LP (2007) Helicobacter pylori inflammation, immunity and vaccines. Helicobacter 12:15-19
6. Minohara Y, Boyd DK, Hawkins HK, Ernst PB, Patel J, Crowe SE (2007) The effect of the cag pathogenicity Island on binding of Helicobacter pylori to gastric epithelial cells and the subsequent induction of apoptosis. Helicobacter 12:583-590
7. Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, Yoshida H, Shiratori Y, Omato M (2001) Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity Island. Clin Diagn Lab Immunol 8:181-186
8. Salehi Z, Jelodar MH, Rassa M, Aheki M (2009) Helicobacter pylori CagA status and peptic ulcer disease in Iran. Dig Dis Sci 54(3):608-613
9. Andrzejewska J, Lee SK, Olbermann P, Lotzing N, Katzowitsch E, Linz B, Achtman M, Kado CI, Suerbaum S, Josenhans C (2006) Characterization of the pili ortholog of the Helicobacter pylori type 4 cag pathogenicity apparatus, a surface-associated protein expressed during infection. J Bacteriol 188:5865-5877
10. Israel DA, Peek RM Jr (2006) The role of persistence in Helicobacter pylori pathogenesis. Curr Opin Gastroenterol 22:3-7
11. Lochhead P, El-Omar EM (2007) Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol 21:281-297
12. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Mémet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Ferrero RL (2004) Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5:1166-1174
13. Correia J, da S, Miranda Y, Leonard Y, Hsu J, Ulevitch RJ (2007) Regulation of NOD1 mediated signalling pathways. Cell Death Differ 14:830-839
14. Fritz JH, Bourhis LL, Sellge G, Magalhaes JG, Fsihi H, Kufer TA, Collins C, Viala J, Ferrero RL, Girardin SE, Philpott DJ (2007) Nod1 mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26:445-459
15. Strober W, Murray PJ, Kitani A, Watanbe T (2006) Signalling pathways and molecular interactions of Nod1 and Nod2. Nat Rev 6:9-20
16. Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Su Q, Saab L, Ogura Y, Kawasaki A, Fukase K, Kusumoto S, Valvano MA, Foster SJ, Mak TW, Nuñez G, Inohara N (2003) An essential role for Nod1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 4:702-707
17. Hasegewa M, Kawasaki A, Yang K, Fujimoto Y, Masumoto J, Breukink E, Nuñez G, Fukase K, Inohara N (2007) A role of lipophilic peptidoglycan related molecules in induction of Nod1- mediated immune responses. J Biol Chem 282:11757-11764
18. Hasegawa M, Yang K, Hashimoto M, Park J-H, Kim Y-G, Fujimoto Y, Nuñez G, Fukase K, Inohara N (2006) Differential release and distribution of Nod 1 and Nod 2 immunostimutory molecules among bacterial species and environments. J Biol Chem 281:29054-29063
19. Mcgovern DPB, Hysi P, Ahmad T, Van Heel DA, Moffatt MF, Carey A, Cookson WOC, Jewll DP (2005) Association between a complex insertion/deletion polymorphism in NOD1 and susceptibility to inflammatory bowel disease. Hum Mol Genet 14:1245-1250
20. Van Limbergen J, Nimmo ER, Russell RK, Drummond HE, Smith L, Anderson NH, Davies G, Arnott ID, Wilson DC, Satsangi J (2007) Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy. Hum Mol Genet 16:2175-2186
21. Hysi P, Kabesch M, Moffatt MF, Schedel M, Carr D, Zhang Y, Boardman B, Mutius E, Weiland SK, Leupold W, Fritzsch C, Klopp N, Musk AW, James A, Nunez G, Inohara N, Cookson WOC (2005) Nod1 variation, immunoglobulin E and asthma. Hum Mol Genet 14:935-941
22. Weidinger S, Klopp N, Rummler L, Wagenpfeil S, Novak N, Baurecht H-J, Groer W, Darsow U, Heinrich J, Gauger A, Schafer T, Jakob T, Behrendt H, Wichmann H-E, Ring J, Illig T (2005) Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J Allergy Clin Immunol 116:177-184
23. Zouali H, Lesage S, Merlin F, Cėzard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassul M, Christensen S, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Chamaillard M, Thomas G, Hugot JP (2003) CARD4/NOD1 is not involved in inflammatory bowel disease. Gut 52:71-74 (Pubitemid 36020768)
24. Hofner P, Gyulai Z, Kiss ZF, Tiszai A, Tiszlavicz L, Gábor T, Szõke D, Molnǎr B, Lonovics J, Tulassay Z, Mǎndi Y (2007) Genetic polymorphisms of Nod1 and IL-8 but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori induced duedonal ulcer and gastritis. Helicobacter 12:124-131
25. Salih BA, Abasiyanik MF, Ahmed N (2007) A preliminary study on the genetic profile of cag pathogenicity-island and other virulent gene loci of Helicobacter pylori strains from Turkey. Infect Genet Evol 7:509-512
26. Sezikli M, Guliter S, Apan TZ, Aksoy A, Keles H, Ozkurt ZN (2006) Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduedonal diseases. J Clin Pract 60:1239-1243
27. Kantarceken B, Aladag M, Atik E, Koksal F, Harputluoglu MM, Harputluoglu H, Karincaoglu M, Ates M, Yildirim B, Hilmioglu F (2003) Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population. World J Gastroenterol 9:1580-1583
28. Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, Tuncer M, Kocazeybek B (2006) Analysis of serum antibody profile against Helicobacter pylori VacA and CagA antigens in Turkish patients with duedonal ulcer. World J Gastroenterol 12:6869-6873
29. Gurbuz AK, Ozel AM, Yazgan Y, Gunay A, Ozdemir S, Demirturk L, Gurol E (2001) Seropositivity against Helicobacter pylori AagA in Turkish gastric cancer patients. J Clin Gastroenterol 33:389-392
30. Serin E, Yilmaz U, Kunefeci G, Kunefeci G, Ozer B, Gumurdulu Y, Guçlu M, Kayaselcuk F, Boyacioǧlu S (2003) Serum positive CagA in patients with non-ulcer dyspepsia and peptic ulcer disease from two centers in different regions of Turkey. World J Gastroenterol 9:833-835
31. Saribasak H, Salih BA, Yamaoka Y, Sander E (2004) Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol 42:1648-1651
32. Yilmaz M, Aydin A, Ungan M, Gunsar F, Ersoz G, Ozutemiz O, Akarca U, Cavusoglu H (1999) The relationship between CagA positivity and serum gastrin and TNF-alpha levels in patients with chronic active gastritis and duedonal ulcer associated with Helicobacter pylori. Turk J Gastroenterol 10:385-390
33. Fenoglio-Preiser CM, Noffsinger AE, Stemmermann GN, Lantz PE, Isaacson PG (2008) The nonneoplastic stomach. In: Lewin KJ, Appelman HD (eds) Gastrointestinal pathology, an atlas and text, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, pp 135-233
34. Molnar T, Hofner P, Nagy F, Lakatos PL, Fischer S, Lakatos L, Kovacs A, Altorjay I, Papp M, Palatka K, Demeter P, Tulassay Z, Nyari T, Miheller P, Papp J, Mandi Y, Lonovics J (2007) NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease. Dig Liver Dis 39:1064-1070
35. Ohkuma K, Okada M, Murayama H, Seo M, Maeda K, Kanda M, Okaba N (2000) Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 15:1105-1112
36. Satoh K, Osawa H, Yoshizawa M, Nakano H, Hirasawa T, Kihira K, Sunago K (2008) Assessment of atrophic gastritis using the OLGA system. Helicobacter 13:225-229
37. Matsuhisa TM, Yamada NY, Kato SK, Matsukura NM (2003) Helicobacter pylori infection, mucosal atrophy and intestinal metaplasia in Asian populations: a comparative study in age, gender and endoscopic diagnosis matched subjects. Helicobacter 8:29-35
38. Ding S-Z, Torok AM, Smith MF, Goldberg JB (2005) Toll like receptor 2 mediated gene expression in epithelial cells during Helicobacter pylori infection. Helicobacter 10:193-204
39. Ding S-Z, Minohara Y, Fan XJ, Wang J, Reyes VE, Patel J, Dirden-Kramer B, Boldogh I, Ernst PB, Crowe SE (2007) Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect Immun 75:4030-4039
40. Weck MN, Brenner H (2008) Association of Helicobacter pylori infection with chronic atrophic gastritis: meta analysis according to type of disease definition. Int J Cancer 123:874-881
41. Le'Negarate G, Ricci V, Hofman V, Mograbi B, Hofman P, Rossi B (2001) Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity Island phenotype. Infect Immun 69:5001-5009
42. Uemura N, Okamato S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. NEJM 345:784-789
43. Mimuro H, Suzuki T, Nagai S, Rieder G, Suzuki M, Nagai T, Fujita Y, Nagamatsu K, Ishijima N, Koyasu S, Haas R, Sasakawa C (2007) Helicobacter pylori dampens gut epithelial self renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe 2:250-263
44. Vorobjova T, Maaroos HI, Uibo R (2008) Immune response to Helicobacter pylori and its association with the dynamics of chronic gastritis in the antrum and corpus. APMIS 116:465-476
45. Hatekeyama M (2006) Helicobacter pylori CagA a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer 119:1217-1223
46. Backert S, Selbach M (2008) Role of type 4 secretion in Helicobacter pylori pathogenesis. Cell Microbiol 10:1573-1581
47. Demirturk L, Melih AM, Yazgan Y, Solmazgul E, Yildirim S, Gultepe M, Gurbuz AK (2001) CagA status in dyspeptic patients with and without peptic ulcer disease in Turkey: association with histopathologic findings. Helicobacter 6:163-168
48. Wu AH, Crabtree JE, Leslie Berstein, Hawtin P, Cockburn M, Chiu-chen Tseng, Forman D (2003) Role of Helicobacter pylori CagA? strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 103:815-821
49. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Aburatani H, Akiyama T Jr, Azuma T, Hatakeyama M (2007) Helicobacter pylori CagA interacts with e-cadherin and deregulates the b-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26:4617-4626
50. Parsonnet J, Freidman GD, Orentreich N, Vogelman H (1997) Risk of gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297-301
51. Fischer W, Püls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R (2001) Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 42:1337-1348
52. Carneiro LAM, Travassos LH, Girardin SE (2007) Nod like receptors in innate immunity and inflammatory diseases. Ann Med 39:581-593
53. Ferrero RL (2005) Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol Immunol 42:879-885
54. Werts C, Girardin SE, Philpott DJ (2006) TIR, CARD and PYRIN: three domains for an antimicrobial triad. Cell Death Differ 13:798-815
55. Yoo NJ, Park WS, Kim SY, Reed JC, Son SG, Lee JY, Lee SH (2002) Nod1, a CARD protein, enhances pro-interleukin-1b processing through the interaction wit pro-caspase 1. Biochem Biophys Res Commun 299:652-658